Skip to main content
Caplight Logo









Morph Labs

Morph Labs

Private
New York City, New YorkAI, Data & Cloud Infrastructurehttps://morph.so

Company Overview

Morph Labs operates in AI, Data & Cloud Infrastructure and is based in New York City, New York. It was founded in 2024.

Morph Labs is a neurotechnology company developing a non-invasive, brain-computer interface to control next-generation prosthetics.

Sector

AI, Data & Cloud Infrastructure

Verticals

Cloud Infrastructure, Platform-as-a-Service, AI Training Infrastructure, NLP & Conversational AI, DevOps & Containers

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Freemium

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Morph Labs Comparables

Compare Morph Labs with similar companies based on industry and business-model similarity.

Morph Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OpenComputer
87%
Mitos
87%
Boxd
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Morph Labs Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Morph Labs. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jesse Han

Founder CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 73% MoM.

  • Nov 9, 2025

    Monthly visitors increased 58% MoM, reaching 7.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Morph Labs Filings

Explore SEC and related filing metadata, where available.

Morph Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Morph Labs's valuation, stock price, and market status.

Is Morph Labs a public or private company?

Morph Labs is a private company.

What is the current stock price of Morph Labs?

Morph Labs is a private company, so its shares have no public market price. Caplight tracks Morph Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Morph Labs worth (valuation)?

Valuation information for Morph Labs is not publicly available.

Can I buy Morph Labs stock?

Morph Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Morph Labs's last funding round?

Funding round information for Morph Labs is not publicly available.

Who are the main investors in Morph Labs?

Investor information for Morph Labs is not publicly disclosed.

Will Morph Labs IPO soon?

No public IPO plans have been announced for Morph Labs.

How can I track Morph Labs secondary market activity?

Caplight tracks bids, offers, and trades in Morph Labs's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range7
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?